
{
  "Company Overview": {
    "Name": "Paushak Ltd",
    "Sector": "Chemicals",
    "Industry": "Chemicals",
    "Business Description": "India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Part of the Alembic group of companies situated in Gujarat, India. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907.",
    "Market Position": "Largest specialty chemical company in India based on Phosgene Chemistry."
  },
  "Financial Metrics": {
    "Market Cap": "₹ 1,559 Cr.",
    "Current Price": "₹ 5,059",
    "High/Low": "₹ 6,399 / ₹ 4,464",
    "P/E Ratio": 27.6,
    "Book Value": "₹ 1,417",
    "Dividend Yield": "0.40 %",
    "ROCE": "16.5 %",
    "ROE": "12.6 %",
    "Face Value": "₹ 10.0",
    "Debt-to-Equity Ratio": null //Not explicitly provided, needs further extraction from Balance Sheet data.
  },
  "Performance Trends": {
    "Sales Growth (5 years)": "8.13%",
    "Quarterly Results": {
      "Sales": [41, 34, 53, 50, 50, 56, 56, 49, 52, 52, 54, 52, 57],
      "Expenses": [23, 22, 32, 32, 33, 35, 37, 36, 38, 33, 35, 40, 40],
      "Operating Profit": [18, 12, 20, 18, 17, 20, 20, 12, 14, 19, 19, 12, 17],
      "OPM %": [43, 34, 39, 37, 33, 37, 35, 25, 28, 36, 35, 23, 30],
      "Other Income": [3, 0, 1, 1, 5, 3, 2, 4, 7, 3, 7, 4, 4],
      "Interest": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
      "Depreciation": [2, 3, 3, 3, 3, 3, 3, 3, 3, 3, 4, 4, 4],
      "Profit before tax": [19, 9, 18, 16, 18, 20, 19, 12, 18, 18, 23, 12, 17],
      "Tax %": [26, 23, 26, 27, 27, 24, 23, 26, 25, 26, 19, 17, 16],
      "Net Profit": [14, 7, 13, 12, 13, 15, 14, 9, 13, 14, 18, 10, 14],
      "EPS in Rs": [46.33, 23.30, 42.89, 37.47, 42.47, 48.73, 46.56, 29.66, 43.25, 44.22, 59.25, 33.45, 46.07]
    },
    "Annual Results": {
      "Sales": [51, 54, 69, 78, 72, 105, 140, 138, 141, 150, 212, 206, 215],
      "Expenses": [39, 43, 52, 61, 60, 75, 99, 95, 91, 96, 137, 142, 148],
      "Operating Profit": [12, 11, 17, 17, 12, 29, 40, 43, 50, 54, 75, 65, 67],
      "OPM %": [23, 20, 25, 22, 17, 28, 29, 31, 36, 36, 35, 31, 31],
      "Other Income": [1, 4, 3, 3, 5, 3, 13, 7, 6, 5, 11, 20, 18],
      "Interest": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
      "Depreciation": [2, 2, 2, 3, 3, 3, 4, 4, 5, 9, 13, 14, 15],
      "Profit before tax": [11, 13, 18, 17, 14, 29, 49, 45, 52, 50, 72, 71, 70],
      "Tax %": [27, 30, 28, 25, 22, 26, 20, 23, 28, 25, 25, 23, 23],
      "Net Profit": [8, 9, 13, 12, 11, 21, 39, 35, 37, 38, 54, 54, 56],
      "EPS in Rs": [24.29, 27.50, 40.50, 38.73, 34.11, 66.95, 126.41, 113.27, 121.02, 122.03, 175.24, 176.34, 182.99]
    },
    "Balance Sheet Highlights": {
      "Equity Capital": [3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3],
      "Reserves": [35, 42, 54, 65, 80, 110, 174, 224, 269, 302, 351, 405, 434],
      "Borrowings": [1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0],
      "Other Liabilities": [8, 8, 11, 13, 11, 31, 36, 43, 57, 61, 61, 73, 75],
      "Total Liabilities": [47, 54, 69, 82, 94, 144, 214, 270, 329, 367, 415, 481, 512],
      "Fixed Assets": [10, 9, 18, 20, 35, 37, 38, 41, 51, 147, 149, 152, 146],
      "CWIP": [0, 4, 1, 12, 0, 1, 6, 16, 68, 8, 7, 29, 85],
      "Investments": [14, 18, 19, 18, 33, 53, 116, 163, 154, 151, 182, 223, 190],
      "Other Assets": [23, 23, 30, 31, 26, 54, 54, 50, 56, 61, 78, 77, 91],
      "Total Assets": [47, 54, 69, 82, 94, 144, 214, 270, 329, 367, 415, 481, 512]
    },
    "Cash Flow Summaries": {
      "Cash from Operating Activity": [2, 9, 9, 14, 12, 10, 24, 45, 30, 44, 43, 56],
      "Cash from Investing Activity": [0, -7, -8, -13, -11, -10, 0, -43, -29, -42, -38, -50],
      "Cash from Financing Activity": [-3, -2, -1, -1, -2, -1, -23, -2, -2, -2, -4, -5],
      "Net Cash Flow": [0, 0, 0, 0, 0, 0, 0, 0, -1, 0, 0, 0]
    }
  },
  "Ratios": {
    "Growth Ratios": {
      "Compounded Sales Growth (10 Years)": "14%",
      "Compounded Sales Growth (5 Years)": "8%",
      "Compounded Sales Growth (3 Years)": "14%",
      "Compounded Sales Growth (TTM)": "1%",
      "Compounded Profit Growth (10 Years)": "18%",
      "Compounded Profit Growth (5 Years)": "9%",
      "Compounded Profit Growth (3 Years)": "10%",
      "Compounded Profit Growth (TTM)": "12%",
      "Stock Price CAGR (10 Years)": "34%",
      "Stock Price CAGR (5 Years)": "16%",
      "Stock Price CAGR (3 Years)": "-15%",
      "Stock Price CAGR (1 Year)": "-11%"
    },
    "Liquidity Ratios": null, // Needs calculation from Balance Sheet data
    "Profitability Ratios": {
      "Return on Equity (10 Years)": "15%",
      "Return on Equity (5 Years)": "14%",
      "Return on Equity (3 Years)": "14%",
      "Return on Equity (Last Year)": "13%",
      "ROCE %": [30, 30, 32, 25, 12, 29, 27, 21, 20, 17, 21, 17]
    },
    "Valuation Ratios": null, //Needs calculation from available data
    "Other Ratios": {
      "Debtor Days": [102, 96, 114, 97, 83, 135, 85, 69, 85, 97, 90, 90],
      "Inventory Days": [133, 117, 96, 117, 125, 118, 122, 131, 148, 233, 180, 177],
      "Days Payable": [79, 71, 94, 104, 70, 170, 73, 110, 118, 227, 122, 130],
      "Cash Conversion Cycle": [155, 142, 116, 110, 138, 83, 133, 89, 115, 103, 149, 137],
      "Working Capital Days": [115, 108, 110, 95, 92, 109, 100, 75, 60, 81, 93, 84]
    }
  },
  "Peer Comparison": {
    "Peers": [
      {"Name": "Pidilite Inds.", "CMP": 2976.80, "P/E": 77.17, "Mar Cap": 151413.76, "Div Yld": 0.54, "NP Qtr": 540.30, "Qtr Profit Var": 18.75, "Sales Qtr": 3234.91, "Qtr Sales Var": 5.16, "ROCE": 29.74},
      {"Name": "SRF", "CMP": 2277.60, "P/E": 59.78, "Mar Cap": 67513.72, "Div Yld": 0.32, "NP Qtr": 201.42, "Qtr Profit Var": -33.03, "Sales Qtr": 3424.30, "Qtr Sales Var": 7.77, "ROCE": 12.71},
      {"Name": "Linde India", "CMP": 6359.80, "P/E": 123.99, "Mar Cap": 54236.37, "Div Yld": 0.06, "NP Qtr": 104.39, "Qtr Profit Var": -2.17, "Sales Qtr": 634.42, "Qtr Sales Var": -10.81, "ROCE": 17.36},
      {"Name": "Gujarat Fluoroch", "CMP": 4329.05, "P/E": 115.96, "Mar Cap": 47554.61, "Div Yld": 0.07, "NP Qtr": 121.00, "Qtr Profit Var": 128.30, "Sales Qtr": 1188.00, "Qtr Sales Var": 25.45, "ROCE": 9.76},
      {"Name": "Godrej Industrie", "CMP": 1119.90, "P/E": 54.56, "Mar Cap": 37712.87, "Div Yld": 0.00, "NP Qtr": 488.86, "Qtr Profit Var": 229.46, "Sales Qtr": 4804.96, "Qtr Sales Var": 22.03, "ROCE": 5.59},
      {"Name": "Deepak Nitrite", "CMP": 2596.85, "P/E": 44.57, "Mar Cap": 35419.23, "Div Yld": 0.29, "NP Qtr": 194.20, "Qtr Profit Var": -5.31, "Sales Qtr": 2032.00, "Qtr Sales Var": 14.28, "ROCE": 21.65},
      {"Name": "Himadri Special", "CMP": 546.85, "P/E": 56.02, "Mar Cap": 26996.96, "Div Yld": 0.09, "NP Qtr": 135.70, "Qtr Profit Var": 34.53, "Sales Qtr": 1136.92, "Qtr Sales Var": 13.18, "ROCE": 18.81}
    ],
    "Median": {
      "CMP": 456.5,
      "P/E": 34.96,
      "Mar Cap": 1547.37,
      "Div Yld": 0.29,
      "NP Qtr": 9.66,
      "Qtr Profit Var": 6.63,
      "Sales Qtr": 168.44,
      "Qtr Sales Var": 6.18,
      "ROCE": 14.5
    }
  },
  "Other Insights": {
    "Pros": "Company is almost debt free.",
    "Cons": [
      "The company has delivered a poor sales growth of 8.13% over past five years.",
      "Company has a low return on equity of 13.5% over last 3 years.",
      "Dividend payout has been low at 10.4% of profits over last 3 years"
    ],
    "Disclaimer": "The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.",
    "Shareholding Pattern Notes": "* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards. Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes. Click on the line-items to see the names of individual entities."
  },
  "Documents": {
    "Announcements": [
      {"Date": "6 Dec", "Title": "Resumption Of Manufacturing Operations"},
      {"Date": "5 Dec", "Title": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate"},
      {"Date": "3 Dec", "Title": "Announcement under Regulation 30 (LODR)-Newspaper Publication"},
      {"Date": "2 Dec", "Title": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate"},
      {"Date": "30 Nov", "Title": "Announcement under Regulation 30 (LODR)-Newspaper Publication"}
    ],
    "Annual Reports": [
      {"Year": 2024, "Source": "bse"},
      {"Year": 2023, "Source": "bse"},
      {"Year": 2022, "Source": "bse"},
      {"Year": 2021, "Source": "bse"},
      {"Year": 2020, "Source": "bse"},
      {"Year": 2019, "Source": "bse"},
      {"Year": 2018, "Source": "bse"},
      {"Year": 2017, "Source": "bse"},
      {"Year": 2016, "Source": "bse"},
      {"Year": 2015, "Source": "bse"},
      {"Year": 2014, "Source": "bse"},
      {"Year": 2013, "Source": "bse"},
      {"Year": 2012, "Source": "bse"},
      {"Year": 2011, "Source": "bse"},
      {"Year": 2010, "Source": "bse"}
    ],
    "Credit Ratings": [
      {"Date": "20 Oct 2023", "Source": "crisil"},
      {"Date": "29 Jul 2022", "Source": "crisil"},
      {"Date": "27 May 2021", "Source": "crisil"},
      {"Date": "17 Feb 2020", "Source": "crisil"},
      {"Date": "17 Dec 2018", "Source": "crisil"}
    ]
  }
}
